In the present study, we have demonstrated that iPA treatment at low micromolar concentrations (10 μm) inhibited aerobic glycolysis of stabilized GBM cells lines, as well a primary cell line (GBM4), reducing PKM2 expression. The gene discussed is PKM; the disease is glioblastoma.